Weeks 1-4: Initiation Phase Starting dose is low to minimize GI side effects Most patients notice reduced appetite within the first 1-2 weeks Mild nausea is common and typically improves within days Weight loss: 2-5 pounds (mostly water and initial caloric reduction) Key focus: Establish protein intake targets and begin resistance training if not already active Baseline DEXA scan and comprehensive bloodwork completed Months 2-3: Dose Escalation Dose increases every 4 weeks toward therapeutic range Appetite suppression becomes more consistent GI side effects may temporarily recur with each dose increase Weight loss: 1-2 pounds per week typical Patients often report improved energy, better sleep, reduced cravings Follow-up bloodwork to check metabolic markers Months 4-6: Therapeutic Phase Most patients have reached their maintenance dose Steady, consistent weight loss of 1-2 pounds per week Visible changes in body composition and clothing fit Metabolic markers (fasting glucose, triglycerides, HbA1c) typically improving Follow-up DEXA scan to verify fat loss vs

Weight Loss Injections (GLP-1s) Weight Loss injections (GLP-1s) are only prescribed via the NHS for those with a BMI greater than 40 with 4 out of 5 medical conditions (detailed below)
Chitosan nanoplexes have been developed for the targeted delivery of miR-200c and miR-141 to breast cancer cells (MCF-7, MDA-MB-231, MDA-MB-435), successfully restoring miRNA expression levels to those observed in non-cancerous cells
+ Earn loyalty points with this purchase Rewards L-Carnitine plays a critical metabolic role in stimulating weight loss
Hydrolyzed Rice Protein and Japanese Parsley Promote skin contour and tone